Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph T Hanlon

Showing results (161-170 of 197) with videos related to

Pageof 20
Sort By:
Journal of the American Geriatrics Society|February 12, 2009
Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition StudyRollin M Wright, Yazan F Roumani, Robert Boudreau, et al.
The Annals of Pharmacotherapy|June 20, 2013
Changes in cholesterol-lowering medications use over a decade in community-dwelling older adultsWei-Hsuan Lo-Ciganic, Robert M Boudreau, Shelly L Gray, et al.
Journal of the American Geriatrics Society|October 19, 2018
Adaptation and Initial Validation of Minimum Data Set (MDS) Mortality Risk Index to MDS Version 3.0Joshua D Niznik, Song Zhang, Maria K Mor, et al.
Circulation. Cardiovascular Quality and Outcomes|May 13, 2020
Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015Kari R Gillmeyer, Seppo T Rinne, Mark E Glickman, et al.
Pharmacoepidemiology and Drug Safety|July 9, 2009
Central nervous system medication use and incident mobility limitation in community elders: the Health, Aging, and Body Composition studyRobert M Boudreau, Joseph T Hanlon, Yazan F Roumani, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 7, 2009
Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition studyJoseph T Hanlon, Robert M Boudreau, Yazan F Roumani, et al.
Research in Social & Administrative Pharmacy : RSAP|September 22, 2018
Characteristics of dual drug benefit use among veterans with dementia enrolled in the Veterans Health Administration and Medicare Part DLoren J Schleiden, Carolyn T Thorpe, John P Cashy, et al.
Journal of the American Geriatrics Society|January 28, 2009
Consensus guidelines for oral dosing of primarily renally cleared medications in older adultsJoseph T Hanlon, Sherrie L Aspinall, Todd P Semla, et al.
Journal of Alzheimer'S Disease : JAD|July 30, 2018
Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy CohortShelly L Gray, Melissa L Anderson, Joseph T Hanlon, et al.
Pain Medicine (Malden, Mass.)|October 14, 2011
Analgesic use for knee and hip osteoarthritis in community-dwelling eldersZachary A Marcum, Subashan Perera, Julie M Donohue, et al.
Pageof 20

Showing results (161-170 of 197) with videos related to

Sort By:
Pageof 20
Journal of the American Geriatrics Society|February 12, 2009
Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition StudyRollin M Wright, Yazan F Roumani, Robert Boudreau, et al.
The Annals of Pharmacotherapy|June 20, 2013
Changes in cholesterol-lowering medications use over a decade in community-dwelling older adultsWei-Hsuan Lo-Ciganic, Robert M Boudreau, Shelly L Gray, et al.
Journal of the American Geriatrics Society|October 19, 2018
Adaptation and Initial Validation of Minimum Data Set (MDS) Mortality Risk Index to MDS Version 3.0Joshua D Niznik, Song Zhang, Maria K Mor, et al.
Circulation. Cardiovascular Quality and Outcomes|May 13, 2020
Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015Kari R Gillmeyer, Seppo T Rinne, Mark E Glickman, et al.
Pharmacoepidemiology and Drug Safety|July 9, 2009
Central nervous system medication use and incident mobility limitation in community elders: the Health, Aging, and Body Composition studyRobert M Boudreau, Joseph T Hanlon, Yazan F Roumani, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 7, 2009
Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition studyJoseph T Hanlon, Robert M Boudreau, Yazan F Roumani, et al.
Research in Social & Administrative Pharmacy : RSAP|September 22, 2018
Characteristics of dual drug benefit use among veterans with dementia enrolled in the Veterans Health Administration and Medicare Part DLoren J Schleiden, Carolyn T Thorpe, John P Cashy, et al.
Journal of the American Geriatrics Society|January 28, 2009
Consensus guidelines for oral dosing of primarily renally cleared medications in older adultsJoseph T Hanlon, Sherrie L Aspinall, Todd P Semla, et al.
Journal of Alzheimer'S Disease : JAD|July 30, 2018
Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy CohortShelly L Gray, Melissa L Anderson, Joseph T Hanlon, et al.
Pain Medicine (Malden, Mass.)|October 14, 2011
Analgesic use for knee and hip osteoarthritis in community-dwelling eldersZachary A Marcum, Subashan Perera, Julie M Donohue, et al.
Pageof 20